Viewing Study NCT03111992


Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2025-12-27 @ 9:54 PM
Study NCT ID: NCT03111992
Status: COMPLETED
Last Update Posted: 2022-02-09
First Post: 2017-03-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module